Fukabori T, Yokomura I, Mizobuchi K, Nakamura M
Dept. of Internal Medicine, Shakaihoken Kobe Central Hospital, Japan.
Gan To Kagaku Ryoho. 1996 Aug;23(9):1187-90.
We report an elderly case of squamous cell lung cancer showing partial response by daily administration of oral etoposide. The 86-year-old man had been diagnosed as squamous cell lung cancer (Stage II, T2N1M0) in September 1992. He had received no active treatment, because he was too old and had pulmonary emphysema. Dyspnea became gradually worse due to complete atelectasis of right lung in December 1994. After treatment with oral etoposide (50 mg/day) for 10 days, atelectasis was reduced and a partial response was obtained. No severe side effect except leukopenia was noted.
我们报告了一例老年鳞状细胞肺癌患者,通过每日口服依托泊苷显示出部分缓解。该86岁男性于1992年9月被诊断为鳞状细胞肺癌(II期,T2N1M0)。由于年龄太大且患有肺气肿,他未接受积极治疗。1994年12月,因右肺完全肺不张,呼吸困难逐渐加重。口服依托泊苷(50毫克/天)治疗10天后,肺不张减轻,获得了部分缓解。除白细胞减少外,未观察到严重副作用。